Effects of Mental Tasks on Breathing Patterns in Adults Using Chronic Opioids vs Non-opioid Users.
AWAKE
Control of Ventilation During Wakefulness in Opioid vs. Non-opioid Patients
1 other identifier
observational
40
1 country
1
Brief Summary
The goal of this observational study is to find out if using your brain for a mental task changes how you breathe. Researchers want to compare three groups of adults: people who take opioid pain medicine every day, people with sleep apnea, and healthy people with neither condition. The main questions this study aims to answer are:
- Does breathing change differently during mental tasks in people who take opioids, people with sleep apnea, and healthy controls?
- Is the connection between brain activity and breathing disrupted more in people who use chronic opioids or have OSA, compared with healthy controls, during periods of mental effort? Researchers will compare the three groups to see if opioid use or sleep apnea makes breathing less steady, or weakens the link between the brain and breathing, when a person is concentrating on a task. Participants will visit the UC San Diego Sleep Laboratory one time. During the visit, they will:
- Answer questions about sleep, opioid use, and sleep apnea risk.
- Have sensors placed on their skin and scalp to measure brain waves, breathing, and oxygen levels. This is the same kind of equipment used in a regular sleep study, and it does not hurt.
- Sit quietly and rest while their breathing and brain waves are recorded.
- Do a series of short mental tasks on a computer, tablet, or paper, testing things like memory, attention, and thinking speed, while their breathing and brain waves continue to be recorded. No medicine or treatment will be given during the study, and no blood or other samples will be collected. This study only involves watching and measuring, not testing any treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 14, 2026
CompletedStudy Start
First participant enrolled
September 16, 2026
CompletedFirst Posted
Study publicly available on registry
September 18, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
September 18, 2026
September 1, 2026
6 months
September 14, 2026
September 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Respiratory pattern changes during standardized cognitive load tasks
2 hours
Respiratory variability/irregularity
Measured from breathing signals (nasal pressure/airflow, thoracoabdominal effort belts, end-tidal CO2) during cognitive tasks vs. baseline
2 hours
Secondary Outcomes (1)
EEG-respiratory coupling
2 hours
Study Arms (3)
Opioid Use
Obstructive Sleep Apnea
Healthy Control Group
Eligibility Criteria
Patients who have been seen at UC San Diego
You may qualify if:
- All participants
- Able to provide informed consent
- Able to communicate in English, see/hear task stimuli (with usual corrective devices), follow multistep instructions, and complete a brief cognitive-task practice example
- Opioid group
- Daily prescribed opioid use, under medical supervision, for chronic non-cancer pain, for ≥3 months
- Prescribed dose ≥20 MME/day (no upper limit)
- Stable dose for ≥2 weeks
- OSA group
- \- Diagnosed OSA with AHI ≥15 events/hour (documented on a prior clinical sleep study)
- Healthy control group
- No history of chronic prescribed opioid use
- No known history/diagnosis of OSA
- If a prior sleep study exists, AHI must be \<10 events/hour within the past 3 years
You may not qualify if:
- Prisoners
- Pregnancy
- BMI \<20 or \>35
- Unable/unwilling to give informed consent or comply with study procedures
- Significant comorbidities of other organ systems (e.g., chronic kidney disease, CHF/active cardiac symptoms, cirrhosis, severe lung disease)
- Diseases affecting respiratory muscles or breathing control (neuromuscular, neurodegenerative, congenital)
- Psychiatric disease other than controlled mood disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California San Diego
San Diego, California, 92037, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeremy Orr, MD
UC San Diego
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Medicine
Study Record Dates
First Submitted
September 14, 2026
First Posted
September 18, 2026
Study Start
September 16, 2026
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
June 1, 2027
Last Updated
September 18, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE